Quantitative Imaging for Smarter Oncology Care
HealthMyne (healthmyne.com) scores 71 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, SaaS brands, Technology brands, in the 27th percentile of 18022 Healthcare brands.
HealthMyne is a healthcare technology company based in Madison, United States, founded in 2013. It provides a quantitative imaging platform that delivers point-of-read clinical decision support for oncology and multidisciplinary care teams. The platform consolidates multiple workflow solutions-such as lung screening and tumor board support-into a single system, aiming to give radiologists, oncologists, cardiologists, and other clinicians actionable imaging insights at the point of care to improve patient management decisions.
| Brand Name | HealthMyne |
|---|---|
| Domain | healthmyne.com |
| Industry | Healthcare, SaaS |
| Founded | 2013 |
| Headquarters | Madison |
| Main Competitors | Aidoc (89/100), Arterys (69/100), Blackford Analysis, Median Technologies, Qlarity Imaging, Philips IntelliSpace Discovery (80/100) |
Moz Domain Authority 33/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Point-of-Read Quantitative Imaging Drives Point-of-Care Decision Support for Oncology and the Multidisciplinary Care Team with Multiple Clinical Decision Support (CDS) Workflow Sol…" (Meta description: 26 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube; no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is HealthMyne?", Claude could identify the brand as of October 2026. HealthMyne is a healthcare technology company that develops quantitative imaging and radiomics software, helping radiologists and oncologists extract measurable biomarker data from medical images like CT and MRI scans. Best known for Quantitative imaging decision support software (QIDS) for radiology and oncology biomarker analysis.
When asked "Best brands similar to HealthMyne?", Claude would recommend HealthMyne as of October 2026. It's a known player in the quantitative imaging and radiomics space, relevant if someone is asking about imaging analytics or precision oncology tools.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
HealthMyne's main competitors in Healthcare: Aidoc (89/100), Arterys (69/100), Philips IntelliSpace Discovery (80/100).
Sources: Brand Analyzer scan
HealthMyne has limited AI-search visibility, scoring 35/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 45, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: HealthMyne official site
HealthMyne was founded in 2013. HealthMyne operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
HealthMyne is headquartered in Madison. HealthMyne operates in the Healthcare category.
Sources: Wikidata
HealthMyne scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: HealthMyne official site
HealthMyne offers a quantitative imaging platform featuring multiple clinical decision support (CDS) workflow solutions, including tools for point-of-care oncology imaging analysis, lung screening workflows, and support for multidisciplinary tumor conference decision-making, all integrated into a single software system.
Sources: HealthMyne official site
HealthMyne is a healthcare technology company headquartered in Madison, United States, founded in 2013. It develops a quantitative imaging platform designed to support clinical decision-making in oncology and related multidisciplinary care settings.
Sources: HealthMyne official site
HealthMyne provides a software platform that combines multiple clinical decision support (CDS) workflow solutions into a single system. The platform delivers quantitative imaging analysis at the point of image read, helping radiologists, oncologists, cardiologists, and multidisciplinary teams make more informed treatment and patient management decisions, including workflows such as lung screening and tumor conference support.
Sources: HealthMyne official site
HealthMyne can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: HealthMyne official site
HealthMyne's platform is used by radiologists, oncologists, cardiologists, and other members of multidisciplinary clinical care teams within healthcare systems who require imaging-driven decision support for oncology and related patient management.
Sources: HealthMyne official site
HealthMyne is known for its point-of-read quantitative imaging approach, which integrates clinical decision support directly into the radiology workflow for oncology and multidisciplinary care teams, consolidating multiple CDS tools into one platform.
Sources: HealthMyne official site
HealthMyne scores 35/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
HealthMyne has a weak AI-visibility profile at 35/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 33/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify HealthMyne from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to HealthMyne: Healthengine (71/100), HealthCareFirst (71/100), HealthTrack (71/100), Healthy Roster (71/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.